Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections

ClinicalTrials.gov ID: NCT00676533

Public ClinicalTrials.gov record NCT00676533. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cipro® XR Excellence in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this clinical trial was to determine the time to improvement of the signs and symptoms (eg, dysuria, frequency, urgency, gross hematuria, suprapubic pain, hesitancy, low back pain) of acute, uncomplicated, symptomatic, lower UTIs in women treated with Cipro XR 500 mg once daily for 3 days.

Study identification

NCT ID
NCT00676533
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bayer
Industry
Enrollment
276 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2003 (Type not available)
Primary completion
Not listed
Completion
Jan 2004 (Actual)
Last update posted
Oct 14, 2013

2003 – 2004

United States locations

U.S. sites
40
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Not listed Birmingham Alabama 35205 —
Not listed Huntsville Alabama 35801 —
Not listed Montgomery Alabama 36106 —
Not listed Tallassee Alabama 36078 —
Not listed Chandler Arizona 85225-2909 —
Not listed Mesa Arizona 85201 —
Not listed Phoenix Arizona 85014 —
Not listed Tempe Arizona 85282 —
Not listed Fresno California 93710 —
Not listed Mission Hills California 91345 —
Not listed San Diego California 92117 —
Not listed San Diego California 92128 —
Not listed San Diego California 92182-4701 —
Not listed Yorba Linda California 92886 —
Not listed Avon Connecticut 06001 —
Not listed Chiefland Florida 32626 —
Not listed Gainesville Florida 32605 —
Not listed Jacksonville Florida 32216 —
Not listed Ocala Florida 34474 —
Not listed Tampa Florida 33607 —
Not listed West Palm Beach Florida 33407 —
Not listed Atlanta Georgia 30308 —
Not listed Atlanta Georgia 30342 —
Not listed Conyers Georgia 30094 —
Not listed Fayetteville Georgia 30214 —
Not listed Hayden Idaho 83835 —
Not listed Evansville Indiana 47713 —
Not listed Baltimore Maryland 21210 —
Not listed Millersville Maryland 21108-1571 —
Not listed Ann Arbor Michigan 48109 —
Not listed Elizabeth New Jersey 07202-3672 —
Not listed Camillus New York 13031 —
Not listed Eugene Oregon 97404 —
Not listed Feasterville Pennsylvania 19053 —
Not listed Simpsonville South Carolina 29681 —
Not listed Lake Jackson Texas 77566 —
Not listed Salt Lake City Utah 84109 —
Not listed Salt Lake City Utah 84121 —
Not listed Seattle Washington 98105-5221 —
Not listed Spokane Washington 99216 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00676533, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2013 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00676533 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →